Apply to attend – Only 500 passes available

Attendance at Advanced Therapies Europe 2025 is limited to just 500 qualified delegates. Whether you're driving investment, scaling manufacturing, or building your next therapeutic breakthrough, your experience will be tailored, targeted, and designed for maximum impact.

Super Early Bird - SOLD OUT!
Early Bird - SOLD OUT!

Standard Pricing Available
 — apply now to secure your place at Europe’s premier cell and gene therapy event.

General Admission

This ticket is strictly for therapeutic developers, pharma, gov/regulators, academics, and non-profits.

  • Access to all content tracks (2 days)
  • Networking opportunities across the event
  • Daily breakfast & lunch included
  • VIP Benefits

Industry Admission

This ticket best for CDMOs, CROs, service providers, consultants, and solution providers supporting the advanced therapies sector.

  • Access to all content tracks (2 days)
  • Networking opportunities across the event
  • Daily breakfast & lunch included
  • VIP Benefits

Start Up Pass

This ticket is strictly for startups. *Subject to approval

  • Access to all content tracks (2 days)
  • Networking opportunities across the event
  • Daily breakfast & lunch included

Investor Pass

This ticket is strictly for investors. 

  • Access to all content tracks (2 days)
  • Networking opportunities across the event
  • Daily breakfast & lunch included
  • Full access to the Investment Summit

 

Current sponsors

Download the 2025 attendee list

Take a sneak peek at who will join us this September

Download the 2025 Attendee List